MAPT and early-onset autosomal dominant Alzheimer disease: Alzheimer’s disease (AD) is generally thought to start with the aggregation of amyloid-β (Aβ) in the brain, followed by deposition of neocortical tau pathology, synaptic dysfunction, atrophy, and cognitive decline [1–3].